Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4681 (MIR4681) is a human microRNA gene that produces a short (about 21–23 nucleotides), single-stranded non-coding RNA molecule involved in post-transcriptional regulation of gene expression[1][3][5]. Like other microRNAs, MIR4681 is expressed as a primary transcript by RNA polymerase II, processed by Drosha and Dicer to a mature microRNA, and incorporated into the RNA-induced silencing complex (RISC), which binds to complementary messenger RNAs to suppress their translation or destabilize the transcript[1][3]. While microRNAs as a class are essential for cellular gene regulation, cell differentiation, proliferation, and death[1][2], there is currently limited or no specific published disease or drug association for MIR4681 itself, and it is not considered a canonical therapeutic target such as a receptor, enzyme, or transporter[3][5]. MIR4681 can be referred by multiple aliases including hsa-mir-4681 and MIR4681; it is designated in genomic databases by identifiers such as HGNC:41753 and NCBI Gene:100616398[3]. Note: There is no evidence in available data that MIR4681 is a direct therapeutic target (such as for a drug, biologic, or small molecule), nor that any approved drugs specifically act via this microRNA[3][5]. There are no known safety concerns or clinical challenges specifically tied to MIR4681, and its precise biological role or disease association in humans remains to be further defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4681 (MIR4681).